- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03689296
Patient-caregiver Collaboration for Better Cardiovascular Care for Patients With Long-term Mental Disorders: Multicentre Qualitative and Feasibility Studies (COPsyCAT)
People with severe and persistent mental disorders (or SMI, Severe Mental Illness) have a life expectancy which is 20 years less than the general population, mainly due to excess mortality related to cardiovascular disease. Moreover, despite an overall increase in life expectancy, the gap is widening between people with long-term psychological disorders and the general population.
This early excess mortality is explained by disparities between people with SMI and the general population not only in access to and use of health services but also in the quality and type of care provided. There is also an over-representation of risk factors and cardiovascular pathologies regardless of the mental disorder, despite the current recommendations for best practices.
The World Health Organization has defined the fight against somatic comorbidities as one of the axes of the European Mental Health Plan and one of the reference themes of the World Health Organization Mental Health Evidence and Research Programme (EPSM-Lille-Métropole). The Groupement de Coopération Sanitaire pour la recherche et la formation en santé mentale, which brings together 17 hospitals in France and relays the actions of the World Health Organization's Collaborating Centre, has decided to make it into a national research project.
Moreover, it is recognized that "medical" management of a disease is all the more effective when the patient is involved. However, the empowerment of people with long-term psychological disorders has never been put at the centre of a strategy to reduce cardiovascular risk.
In this context, we hypothesize that one of the keys to reducing cardiovascular risk would be to take into account the experience and representations of this risk by all stakeholders (people with long-term psychological disorders, their carers, primary health professionals and psychiatric professionals).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Frédéric DENIS
- Phone Number: +33 3 80 42 56 59
- Email: frederic.denis@chlcdijon.fr
Study Locations
-
-
-
Dijon, France, 21000
- Recruiting
- Chu Dijon Bourogne
-
Contact:
- Frédéric DENIS
- Phone Number: +33 3 80 42 56 59
- Email: frederic.denis@chlcdijon.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
For all groups:
- Adult person,
- Person who has given his or her consent to participate in the study, with the consent of the tutor in the context of guardianship,
- Fluent use of the French language,
For the "Users" group:
- Person with a long-term psychological disorder: Long-term illness (ALD 23), followed by outpatient or full hospitalization
For the "Caregivers" group:
- Adult helping a person with a long-term psychological disorder with a Long-Term Disability (ALD 23) and who has given his or her consent to be contacted for the study,
For the "Primary Care Professionals" group:
- Primary care professional in practice following at least one person with a long-term psychological disorder with a Long-Term Disability (ALD 23),
- For the "Psychiatric Professionals" group - Professional currently in practice who is part of a psychiatry team or in private practice
Exclusion Criteria:
1. For all groups:
- Person who is physically or psychologically unable to participate in the focus group and/or program at the time of the study
- Person not affiliated to the National Health Insurance
- Objection to participation by the patient or his legal representative, carers and health professionals.
- Patient under guardianship
- Patient who participated in Phase 1 or 2 of the study
- Patient not able to attend the 6-month visit
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Users
Person with a long-term mental disorder
|
Focus group interviews conducted by two health sociologists in 4 distinct categories: caregivers, patients, primary health care professionals and psychiatric professionals.
Conduct of exploratory semi-directive interviews with users, caregivers, primary health care professionals and psychiatric professionals by a health sociologist
|
Caregivers
Adult helping a person with a long-term psychological disorder
|
Focus group interviews conducted by two health sociologists in 4 distinct categories: caregivers, patients, primary health care professionals and psychiatric professionals.
Conduct of exploratory semi-directive interviews with users, caregivers, primary health care professionals and psychiatric professionals by a health sociologist
|
Primary care professionals
Primary care professional in practice following at least one person with a long-term mental disorder
|
Focus group interviews conducted by two health sociologists in 4 distinct categories: caregivers, patients, primary health care professionals and psychiatric professionals.
Conduct of exploratory semi-directive interviews with users, caregivers, primary health care professionals and psychiatric professionals by a health sociologist
|
Psychiatric professionals
Psychiatric specialist working in a hospital or in private practice
|
Focus group interviews conducted by two health sociologists in 4 distinct categories: caregivers, patients, primary health care professionals and psychiatric professionals.
Conduct of exploratory semi-directive interviews with users, caregivers, primary health care professionals and psychiatric professionals by a health sociologist
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Focus group interview completion
Time Frame: Through study completion, an average of 14 months
|
Through study completion, an average of 14 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DENIS PREPS 2017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Long-term Mental Disorders
-
Ian StewartNaval Health Research CenterTerminatedCombat Disorders | Long Term Adverse EffectsUnited States
-
Prof. Dominique de Quervain, MDClinical Trial Unit, University Hospital Basel, SwitzerlandCompletedMemory, Short-Term | Memory, Long-TermSwitzerland
-
National Taipei University of Nursing and Health...CompletedAged | Long-Term CareTaiwan
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)Recruiting
-
National Taiwan University HospitalCompletedLong-term CareTaiwan
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruitingLong-Term SurvivorsFrance
-
Cristina García-VivarInstituto de Salud Carlos IIINot yet recruitingLong-term Effects Secondary to Cancer Therapy in Adults | Long-term Effects of Cancer Treatment
-
University Hospital TuebingenJoachim Riethmueller, Dr. med.UnknownLong Term VentilationGermany
-
National Taipei University of Nursing and Health...Recruiting
Clinical Trials on Questionnaires (Phase 3)
-
Loma Linda UniversityCompletedAmputation; Traumatic, Leg, LowerUnited States
-
Sun Yat-sen UniversityNot yet recruiting
-
Hospices Civils de LyonCompletedHereditary Hemorrhagic TelangiectasiaFrance
-
University of ThessalyCompletedOverweight and ObesityGreece
-
Janssen Research & Development, LLCCompletedRelapsed or Refractory Hodgkin LymphomaFrance, Germany
-
Ant ShepherdHampshire Hospitals NHS Foundation TrustUnknown
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)CompletedOpioid Abuse (Disorder)United States
-
Drexel UniversityEsperanza Health Center; The Philadelphia AIDS ConsortiumRecruitingAnxiety Disorders | Post Traumatic Stress Disorder | Depression, UnipolarUnited States
-
VA Office of Research and DevelopmentCompleted